ArticleAlimentary pharmacology & therapeutics2026
Inflammatory Bowel Disease Is Associated With an Increased Risk of End-Stage Renal Disease: A Population-Based Cohort Study.
Article in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inflammatory Bowel Disease Is Associated With an Increased Risk of End-Stage Renal Disease: A Population-Based Cohort Study.Alimentary pharmacology & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundInflammatory bowel disease (IBD) is associated with renal complications, but population-based data on end-stage renal disease (ESRD) are limited.
aimTo evaluate the incidence of ESRD and renal transplantation in IBD compared with the general population and to identify predictive factors associated with ESRD in the IBD population.
methodsThis was a retrospective population-based cohort study using the University of Manitoba IBD Epidemiology Database linked to administrative healthcare data from 1984 to 2023 (12,639 IBD patients matched with 126,180 controls). ESRD was defined as requiring any two claims for outpatient dialysis within a 1-year period. Predictive factors were identified using proportional hazard regression and nested case-control logistic regression analyses.
resultsIBD patients had a significantly higher incidence of dialysis (1.48% vs. 0.82%, p < 0.0001) and kidney transplantation (0.25% vs. 0.10%, p < 0.0001) than controls. IBD was an independent predictor of ESRD (HR = 1.53, 95% CI 1.23-1.90), with stronger associations in CD (HR = 1.93, 95% CI 1.39-2.68) than UC (HR = 1.28, 95% CI 0.96-1.72). Traditional risk factors including diabetes (HR = 3.82, 95% CI 3.22-4.53), hypertension (HR = 1.91, 95% CI 1.58-2.30), and congestive heart failure (HR = 6.37, 95% CI 5.25-7.72) remained strongly predictive. Within the IBD population, oral steroid treatment (OR = 2.0, 95% CI 1.06-3.81), allopurinol use (OR = 4.06, 95% CI 1.49-11.1) and bowel surgery (OR = 2.77, 95% CI 1.51-5.09) significantly predicted dialysis initiation.
conclusionsPersons with IBD have an increased risk of ESRD by nearly 50%, with CD showing a greater risk than UC. Bowel surgery, allopurinol use and oral steroid therapy are important predictors, emphasising the necessity of careful renal monitoring in IBD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.